Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06670495

HPV Genotype Attribution and Disease Burden of Anal Cancer in China

Understanding the Human Papillomavirus Genotype Attribution and Disease Burden of Anal Cancer in China: A Multicenter Hospital-based Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Fudan University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To demonstrate HPV prevalence and its genotype distributions in anal cancer in China and to describe demographic and clinical features of HPV-related anal cancer in China; To describe the epidemiological characteristics ,trends and of disease burden of anal cancer in China

Conditions

Timeline

Start date
2025-06-01
Primary completion
2027-12-31
Completion
2028-12-31
First posted
2024-11-01
Last updated
2026-02-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06670495. Inclusion in this directory is not an endorsement.